Amoy Diagnostics (300685.SZ) has completed its repurchase, spending a total of 101 million yuan to repurchase 1.35% of its shares.
Ed Bio (300685.SZ) announced that the company's share repurchase plan has been completed as of February 2025...
Amoy Diagnostics (300685.SZ) announced that the share repurchase plan has been completed. As of February 25, 2025, the company has repurchased a total of 5.3748 million shares through centralized bidding trading, accounting for 1.35% of the current total share capital. The total transaction amount is 101 million yuan (excluding trading fees).
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


